• 10 mM dNTP Mixture for PCR and LNP Studies

  2026-09-10

  The 10 mM dNTP mixture provides a controlled nucleotide input for PCR, qPCR, sequencing preparation, and DNA reporter workflows. Paired with the reference study’s intracellular trafficking model, it helps separate DNA production quality from the effects of lipid composition and cholesterol on delivery.

• Thioredoxin Control of CHK1 Inhibitor Sensitivity

  2026-09-10

  This study identifies thioredoxin 1 as a determinant of CHK1 inhibitor sensitivity in non-small cell lung cancer and links that phenotype to redox control of ribonucleotide reductase. Its findings provide a mechanistic basis for combining replication-stress inhibitors with thioredoxin-system perturbation while highlighting the need for tumor-selective strategies that limit toxicity.

• PEP, cGAS–STING, and Healthy Aging

  2026-09-09

  A 2026 Nature Aging study identifies phosphoenolpyruvate (PEP) as an endogenous metabolic brake on cGAS–STING-driven inflammation. Longitudinal profiling, mouse perturbation experiments, human association data, and binding analyses connect PEP to inflammaging, healthy aging, and neuroinflammation while highlighting important limits for translation.

• Netarsudil (AR-13324) Assay Workflow Guide

  2026-09-09

  This scenario-based guide shows how Netarsudil (AR-13324), SKU B7807, can improve interpretation of viability, proliferation, cytotoxicity, and cytoskeletal assays. It connects ROCK biology with formulation, siRNA codelivery, solvent control, and practical product-selection decisions.

• Schwartz 2022: Measuring Drug Responses in Cancer

  2026-09-08

  Hannah Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell death are related but non-equivalent dimensions of in vitro drug response. This framework encourages cancer researchers to measure both outcomes over time rather than treating a single viability score as a complete description of drug activity.

• CpAdhE Inhibition by Antifungal Imidazoles

  2026-09-08

  The reference study identifies the bacterial-type bifunctional aldehyde/alcohol dehydrogenase CpAdhE as a chemically vulnerable enzyme in Cryptosporidium parvum. Its staged combination of biochemical screening, kinetic analysis, parasite growth assays, and cytotoxicity testing provides a useful framework for evaluating metabolic drug targets and prioritizing anti-cryptosporidial leads.

• Prenatal Nanoplastics and Vascular Lipid Dysregulation

  2026-09-07

  The 2026 reference study shows that prenatal and lactational exposure to 100-nm polystyrene nanoplastics promotes lipid accumulation in the aortic media of male mouse offspring and in cultured vascular smooth muscle cells. Its mechanistic contribution is the identification of a MAPK/ERK/UHRF1 signaling axis, supported by ERK inhibition and UHRF1 knockdown, that links early-life nanoplastic exposure with disrupted vascular lipid homeostasis.

• Reversine and the Mitotic Checkpoint Decision

  2026-09-07

  Reversine is an Aurora kinase inhibitor that can be used to interrogate how mitotic disruption intersects with checkpoint silencing. This article connects its Aurora A/B/C activity with the Plk1–p31comet–MCC mechanism and translates that biology into practical assay decisions.

• Sulforaphane Workflows for Stress and Cancer Research

  2026-09-05

  Sulforaphane supports reproducible cell-based studies spanning Nrf2-mediated oxidative stress, G2/M arrest, and apoptosis, while newer mouse evidence extends its utility to ROS-driven NLRP3 inflammasome research. This guide converts those mechanisms into practical assay workflows, controls, optimization decisions, and troubleshooting steps.

• Tigecycline for Reproducible MDR Assays

  2026-09-04

  Learn how Tigecycline, SKU A5226, can support controlled antimicrobial, resistance, and host-cell compatibility workflows. This scenario-based guide covers assay design, stock preparation, data interpretation, and practical supplier selection using product data and recent CREC surveillance findings.

• Epalrestat Activates KEAP1/Nrf2 in Parkinson’s Models

  2026-09-04

  Jia et al. report that Epalrestat, an aldose reductase inhibitor, protects dopaminergic neurons in cellular and mouse Parkinson’s disease models by reducing oxidative stress and mitochondrial dysfunction. The study’s central innovation is evidence that Epalrestat directly and competitively binds KEAP1, promotes KEAP1 degradation, and activates Nrf2 signaling, supporting a preclinical repurposing hypothesis rather than establishing clinical efficacy.

• Elobixibat hydrate: IBAT Research Workflows

  2026-09-03

  Elobixibat hydrate connects selective ileal bile acid transporter inhibition with practical assays for intestinal motility, bile acid signaling, and metabolic readouts. This workflow-focused guide shows how to control solvent effects, select translational endpoints, and interpret findings without overstating evidence from a small pilot study.

• Vemurafenib (PLX4032) Research Workflows

  2026-09-03

  Build more informative BRAF-mutant melanoma experiments with Vemurafenib (PLX4032), from genotype-matched viability assays to early signaling and resistance profiling. This workflow emphasizes solubility control, pathway-specific readouts, and multi-omics-guided troubleshooting rather than relying on a single endpoint.

• (S)-(+)-Dimethindene maleate Workflow Guide

  2026-09-02

  This dossier-based guide explains how to use (S)-(+)-Dimethindene maleate as an M2 muscarinic receptor antagonist when separating muscarinic effects from histamine H1 activity is important. It is intended for controlled scientific research workflows, not diagnostic, therapeutic, or medical use, and should not be treated as a substitute for directly matched literature evidence.

• Fluoxetine HCl: From Serotonin to Motivation

  2026-09-02

  Fluoxetine HCl is more than a standard serotonergic tool: interpreted alongside developmental SSRI findings, it can help translational researchers separate serotonin transport, 5HT2C signaling, neuroplasticity, and nucleus accumbens reward circuitry.

8490 records 1/566 page Next 12345 下5页 Last page